Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items
It's the cost of living, stupid: Why progressives lose and win
UK households are impatient for change. Trust in our political system is low and that’s reflected in scepticism across the board that government can make things better.Getting the child poverty strategy we need: A co-produced agenda for change
The UK government has a time-limited opportunity to make a decisive difference to child poverty in its upcoming strategy.Not yet settled? Assessing the government’s new policy on indefinite leave to remain
This month’s white paper represented the most significant shake-up in immigration policy since Brexit.